Fannin Goldenrod Holdings — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Goldenrod Therapeutics, Inc.Jun 2026SEC filingmedium confidence
BiotechHouston, US
Dev Chatterjee(Executive Officer)Leo Linbeck IV(Executive Officer)Mark Worscheh(Executive Officer, Director)Atul Varadhachary(Executive Officer, Director)Leo Linbeck III(Director)Thomas Brenninkmeijer(Director)
Board seatLeo Linbeck III· per SEC Form D · $6.5M raise · filed Jun 2026
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.